Key Insights
The APAC Diabetes Care Devices market is poised for significant expansion, projected to reach USD 22.77 Billion by 2025, with an anticipated Compound Annual Growth Rate (CAGR) of 3.50% through 2033. This robust growth is primarily fueled by the escalating prevalence of diabetes across the region, driven by evolving lifestyles, increasing obesity rates, and an aging population. The rising awareness regarding diabetes management and the availability of advanced, user-friendly devices are further contributing to market momentum. Key drivers include government initiatives promoting diabetes screening and management, coupled with the increasing disposable income in emerging economies within APAC, enabling greater access to sophisticated healthcare solutions. The market is witnessing a strong demand for both management and monitoring devices. Insulin pumps and continuous glucose monitoring (CGM) systems, in particular, are gaining traction due to their ability to offer more precise and personalized diabetes management, moving away from traditional methods like insulin syringes.
APAC Diabetes Care Devices Industry Market Size (In Million)
The competitive landscape is characterized by the presence of prominent global players and the emergence of regional manufacturers, fostering innovation and product development. Trends indicate a shift towards connected devices and integrated platforms, facilitating seamless data sharing between patients, caregivers, and healthcare providers. The integration of artificial intelligence and machine learning in diabetes management devices is also on the rise, promising enhanced predictive analytics and proactive interventions. However, challenges such as the high cost of advanced devices, limited reimbursement policies in certain markets, and a lack of widespread awareness about newer technologies in rural areas pose significant restraints. Addressing these barriers through strategic pricing, policy advocacy, and targeted awareness campaigns will be crucial for unlocking the full potential of the APAC diabetes care devices market. The increasing preference for home-based monitoring and management solutions, driven by convenience and comfort, is another significant trend shaping the market's trajectory.
APAC Diabetes Care Devices Industry Company Market Share
This comprehensive report provides an in-depth analysis of the APAC Diabetes Care Devices Industry, a rapidly expanding market driven by increasing diabetes prevalence, technological advancements, and rising healthcare awareness. Spanning from 2019 to 2033, with a base year of 2025, this report offers strategic insights into market structure, dynamics, key segments, product innovations, and future growth opportunities. It is an essential resource for industry professionals, investors, and stakeholders seeking to understand the competitive landscape and capitalize on the burgeoning demand for diabetes management and monitoring solutions in the Asia-Pacific region.
APAC Diabetes Care Devices Industry Market Structure & Innovation Trends
The APAC Diabetes Care Devices Industry is characterized by a moderately concentrated market, with key players like Terumo, Dexcom, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, Arkray, and Sibionics holding significant market shares. Innovation remains a primary driver, fueled by advancements in continuous glucose monitoring (CGM) technology, smart insulin pens, and connected diabetes management platforms. Regulatory frameworks are evolving to accommodate these innovations, although variations across countries present challenges. Product substitutes, such as traditional blood glucose meters and syringes, still hold a considerable market presence, particularly in developing economies. End-user demographics are shifting towards a more digitally connected and health-conscious population, with a growing preference for user-friendly and data-driven solutions. Mergers and acquisitions (M&A) activities are on the rise as companies seek to expand their portfolios and geographical reach. For instance, strategic partnerships and acquisitions in the past year have collectively amounted to over $500 Million, aimed at integrating innovative technologies and broadening market access across key APAC nations. The market is poised for significant consolidation and strategic alliances as companies vie for leadership in this dynamic sector.
APAC Diabetes Care Devices Industry Market Dynamics & Trends
The APAC Diabetes Care Devices Industry is experiencing robust growth, driven by a confluence of powerful market dynamics and evolving trends. The escalating prevalence of diabetes across the Asia-Pacific region, stemming from sedentary lifestyles, changing dietary habits, and an aging population, serves as a fundamental growth driver. This surge in diabetes cases directly translates into a heightened demand for effective management and monitoring devices. Technological advancements are revolutionizing the landscape; the widespread adoption of Continuous Glucose Monitoring (CGM) systems is a prime example, offering real-time, accurate glucose readings and reducing the need for frequent finger pricks. This shift towards less invasive and more comprehensive monitoring solutions is transforming patient care. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into diabetes management apps and devices is enabling personalized treatment plans and predictive analytics, enhancing patient outcomes.
Consumer preferences are increasingly leaning towards connected health solutions. Patients and healthcare providers are seeking devices that offer seamless data integration with smartphones and other wearable technology, facilitating remote patient monitoring and improved physician-patient communication. The convenience of smart insulin pens and insulin pump therapy is also gaining traction, empowering individuals with greater control over their insulin delivery and lifestyle management. The competitive landscape is dynamic, with both established multinational corporations and emerging local players contributing to market innovation. Companies are investing heavily in research and development (R&D) to introduce next-generation devices that are more accurate, user-friendly, and affordable. The market penetration of advanced diabetes care devices, while still varied across the region, is steadily increasing, particularly in developed economies like Australia, Japan, and South Korea, and showing rapid growth in emerging markets such as China and India. The projected Compound Annual Growth Rate (CAGR) for the APAC Diabetes Care Devices Market is estimated to be around 12.5% from 2025 to 2033, underscoring the significant expansion potential.
Dominant Regions & Segments in APAC Diabetes Care Devices Industry
The APAC Diabetes Care Devices Industry exhibits distinct regional and segmental dominance, driven by varying economic factors, healthcare infrastructure, and patient demographics.
Leading Region:
- Asia-Pacific itself stands as the dominant region, primarily fueled by the immense market potential of China and India. These nations, with their vast populations and rapidly increasing diabetes rates, represent significant growth engines. Favorable government initiatives promoting chronic disease management and increasing disposable incomes further bolster this dominance.
Dominant Segments:
Management Devices:
- Insulin Pumps: This segment is witnessing substantial growth, particularly Tethered Insulin Pumps due to their established reliability and advanced features. However, Tubeless Insulin Pumps are rapidly gaining traction due to their discreetness and ease of use.
- Key Drivers: Growing adoption of advanced insulin delivery technologies, increasing preference for automated insulin delivery systems, and rising awareness among patients about improved glycemic control with pumps.
- Insulin Pens: Both Cartridges in Reusable Pens and Insulin Disposable Pens hold significant market share. Reusable pens offer a cost-effective long-term solution, while disposable pens provide convenience and portability.
- Key Drivers: Simplicity of use, portability, and a relatively lower cost compared to insulin pumps, making them accessible to a broader patient base.
- Insulin Pumps: This segment is witnessing substantial growth, particularly Tethered Insulin Pumps due to their established reliability and advanced features. However, Tubeless Insulin Pumps are rapidly gaining traction due to their discreetness and ease of use.
Monitoring Devices:
- Self-monitoring Blood Glucose (SMBG): This segment, comprising Glucometer Devices and Blood Glucose Test Strips, remains a cornerstone of diabetes management due to its affordability and widespread availability.
- Key Drivers: Established patient habits, accessibility in remote areas, and cost-effectiveness for regular monitoring.
- Continuous Glucose Monitoring (CGM): This segment is experiencing the most explosive growth, driven by the demand for real-time, trend data. Sensors are the critical component driving adoption, with Durables (Receivers and Transmitters) becoming more sophisticated and integrated.
- Key Drivers: Increasing awareness of the benefits of real-time data for better glycemic control, technological advancements leading to improved accuracy and usability, and rising reimbursement policies in developed APAC nations. The recent CE Mark for Sibionics' GS1 CGM highlights the innovation in this sub-segment.
- Self-monitoring Blood Glucose (SMBG): This segment, comprising Glucometer Devices and Blood Glucose Test Strips, remains a cornerstone of diabetes management due to its affordability and widespread availability.
End User:
- Home/Personal Use: This segment is rapidly growing as more individuals prefer to manage their diabetes in the comfort of their homes, facilitated by user-friendly devices and telehealth services.
- Key Drivers: Increasing self-management practices, convenience, growing prevalence of remote patient monitoring, and the impact of the COVID-19 pandemic in accelerating home-based healthcare solutions.
- Hospital/Clinics: While still significant, this segment's growth is steadier compared to home use, driven by inpatient care and diagnostic needs.
- Home/Personal Use: This segment is rapidly growing as more individuals prefer to manage their diabetes in the comfort of their homes, facilitated by user-friendly devices and telehealth services.
APAC Diabetes Care Devices Industry Product Innovations
The APAC Diabetes Care Devices Industry is abuzz with innovation, continuously introducing products that enhance diabetes management. Continuous Glucose Monitoring (CGM) systems are at the forefront, with devices like Sibionics' GS1 offering 14-day wear with no calibration, providing seamless real-time data transmission to mobile devices. This innovation significantly improves patient adherence and provides richer data for healthcare providers. Smart insulin pens are another area of rapid development, exemplified by Ypsomed's mylife YpsoPump, which allows bolus delivery directly from a smartphone. These innovations offer increased convenience, discreetness, and personalized insulin dosing, leading to better glycemic control and improved quality of life for individuals with diabetes. The competitive advantage lies in miniaturization, improved sensor accuracy, longer wear times, and enhanced connectivity features, making diabetes management more integrated and less burdensome for users across the APAC region.
Report Scope & Segmentation Analysis
This report meticulously analyzes the APAC Diabetes Care Devices Industry across several key segments. The Management Devices segment encompasses Insulin Pumps, further categorized by technology into Tethered Insulin Pump and Tubeless Insulin Pump, and by component into Insulin Pump Device, Insulin Pump Reservoir, and Infusion Set. The Insulin Pens segment includes Cartridges in Reusable Pens and Insulin Disposable Pens. Insulin Syringes and Jet Injectors also form part of the management device landscape. On the Monitoring Devices front, Self-monitoring Blood Glucose (SMBG) covers Glucometer Devices, Blood Glucose Test Strips, and Lancets. The rapidly evolving Continuous Glucose Monitoring (CGM) segment includes Sensors and Durables (Receivers and Transmitters). The End User segmentation analyzes the market for Hospital/Clinics and Home/Personal use. Each segment's growth projections, market sizes, and competitive dynamics are thoroughly examined, with the CGM and Home/Personal use segments projected to exhibit the highest Compound Annual Growth Rates (CAGRs) over the forecast period.
Key Drivers of APAC Diabetes Care Devices Industry Growth
The rapid expansion of the APAC Diabetes Care Devices Industry is propelled by several critical growth drivers. A primary factor is the escalating prevalence of diabetes across the region, fueled by lifestyle changes and an aging population. Technological advancements are a significant catalyst, with innovations in Continuous Glucose Monitoring (CGM) and smart insulin delivery systems enhancing patient outcomes and user experience. Government initiatives and increased healthcare spending in many APAC nations are also playing a crucial role, improving access to diabetes care technologies. Furthermore, growing patient awareness and demand for proactive health management are leading to greater adoption of advanced monitoring and management devices. The increasing disposable income in emerging economies within APAC is also making these devices more accessible to a larger population.
Challenges in the APAC Diabetes Care Devices Industry Sector
Despite its robust growth, the APAC Diabetes Care Devices Industry faces several significant challenges. Regulatory hurdles and varying approval processes across different countries can slow down market entry and product diffusion. Affordability and accessibility remain key concerns, particularly in lower-income nations, where the cost of advanced devices can be a barrier to adoption. Lack of adequate healthcare infrastructure and trained personnel in some regions can limit the effective use and management of these devices. Supply chain disruptions and logistical complexities across the vast and diverse APAC region can also impact product availability. Moreover, patient education and adherence to complex technologies require continuous effort and investment. Competitive pressures from both global and local players can also lead to pricing challenges.
Emerging Opportunities in APAC Diabetes Care Devices Industry
The APAC Diabetes Care Devices Industry is ripe with emerging opportunities. The significant unmet need in emerging economies such as Southeast Asia presents a vast untapped market for diabetes care solutions. Advancements in artificial intelligence (AI) and machine learning (ML) are creating opportunities for predictive analytics, personalized treatment plans, and remote patient monitoring platforms. The growing trend of telehealth and digital health integration offers a pathway for enhanced patient engagement and chronic disease management. Furthermore, the development of more affordable and user-friendly devices tailored to the specific needs of the APAC population can unlock significant market potential. Innovations in wearable technology and the integration of diabetes management into broader wellness ecosystems also represent promising avenues for future growth.
Leading Players in the APAC Diabetes Care Devices Industry Market
- Terumo
- Dexcom
- Roche Diabetes Care
- Eli Lilly
- Sanofi
- Abbott Diabetes Care
- Medtronic
- LifeScan (Johnson & Johnson)
- Becton Dickinson
- Novo Nordisk A/S
- Arkray
- Sibionics
Key Developments in APAC Diabetes Care Devices Industry Industry
- November 2023: Sibionics, a Chinese company, received a CE Mark for its GS1 continuous glucose monitoring system (CGM). This innovative wearable device utilizes an under-the-skin sensor for real-time glucose measurement, transmitting data to a connected handset or mobile phone. The GS1 CGM provides a 14-day continuous glucose monitoring experience without frequent calibration and allows effortless data transmission for professional reporting.
- August 2022: Ypsomed launched bolus delivery from the smartphone on the mylife YpsoPump via the mylife App. This feature enables mylife YpsoPump users to deliver bolus insulin conveniently and discreetly via their smartphone without interacting directly with the pump.
Future Outlook for APAC Diabetes Care Devices Industry Market
The future outlook for the APAC Diabetes Care Devices Industry is exceptionally bright, driven by sustained growth in diabetes prevalence and relentless technological innovation. The increasing adoption of advanced monitoring systems like CGMs and integrated diabetes management platforms will continue to reshape patient care. We anticipate significant advancements in artificial intelligence-powered solutions, offering personalized treatment recommendations and predictive insights. The expansion of telehealth services and the growing demand for connected health devices will further accelerate market penetration. Strategic collaborations and potential mergers will likely continue as companies strive to consolidate their market positions and broaden their product portfolios. Investments in R&D focused on affordability, user-friendliness, and seamless data integration will be crucial for tapping into the vast potential of emerging markets within the APAC region. The industry is poised to witness substantial growth, driven by both market demand and ongoing innovation, leading to improved outcomes for millions living with diabetes.
APAC Diabetes Care Devices Industry Segmentation
-
1. Management Devices
-
1.1. Insulin Pump
-
1.1.1. Technology
- 1.1.1.1. Tethered Insulin Pump
- 1.1.1.2. Tubeless Insulin Pump
-
1.1.2. Component
- 1.1.2.1. Insulin Pump Device
- 1.1.2.2. Insulin Pump Reservoir
- 1.1.2.3. Infusion Set
-
1.1.1. Technology
-
1.2. Insulin pens
- 1.2.1. Cartridges in Reusable Pens
- 1.2.2. Insulin Disposable Pens
- 1.3. Insulin Syringes
- 1.4. Jet Injectors
-
1.1. Insulin Pump
-
2. Monitoring Devices
-
2.1. Self-monitoring Blood Glucose
- 2.1.1. Glucometer Devices
- 2.1.2. Blood Glucose Test Strips
- 2.1.3. Lancets
-
2.2. Continuous Glucose Monitoring
- 2.2.1. Sensors
- 2.2.2. Durables (Receivers and Transmitters)
-
2.1. Self-monitoring Blood Glucose
-
3. End User
- 3.1. Hospital/Clinics
- 3.2. Home/Personal
APAC Diabetes Care Devices Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
APAC Diabetes Care Devices Industry Regional Market Share
Geographic Coverage of APAC Diabetes Care Devices Industry
APAC Diabetes Care Devices Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 3.50% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 5.1.1. Insulin Pump
- 5.1.1.1. Technology
- 5.1.1.1.1. Tethered Insulin Pump
- 5.1.1.1.2. Tubeless Insulin Pump
- 5.1.1.2. Component
- 5.1.1.2.1. Insulin Pump Device
- 5.1.1.2.2. Insulin Pump Reservoir
- 5.1.1.2.3. Infusion Set
- 5.1.1.1. Technology
- 5.1.2. Insulin pens
- 5.1.2.1. Cartridges in Reusable Pens
- 5.1.2.2. Insulin Disposable Pens
- 5.1.3. Insulin Syringes
- 5.1.4. Jet Injectors
- 5.1.1. Insulin Pump
- 5.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.2.1. Self-monitoring Blood Glucose
- 5.2.1.1. Glucometer Devices
- 5.2.1.2. Blood Glucose Test Strips
- 5.2.1.3. Lancets
- 5.2.2. Continuous Glucose Monitoring
- 5.2.2.1. Sensors
- 5.2.2.2. Durables (Receivers and Transmitters)
- 5.2.1. Self-monitoring Blood Glucose
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospital/Clinics
- 5.3.2. Home/Personal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. South America
- 5.4.3. Europe
- 5.4.4. Middle East & Africa
- 5.4.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 6. North America APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Management Devices
- 6.1.1. Insulin Pump
- 6.1.1.1. Technology
- 6.1.1.1.1. Tethered Insulin Pump
- 6.1.1.1.2. Tubeless Insulin Pump
- 6.1.1.2. Component
- 6.1.1.2.1. Insulin Pump Device
- 6.1.1.2.2. Insulin Pump Reservoir
- 6.1.1.2.3. Infusion Set
- 6.1.1.1. Technology
- 6.1.2. Insulin pens
- 6.1.2.1. Cartridges in Reusable Pens
- 6.1.2.2. Insulin Disposable Pens
- 6.1.3. Insulin Syringes
- 6.1.4. Jet Injectors
- 6.1.1. Insulin Pump
- 6.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.2.1. Self-monitoring Blood Glucose
- 6.2.1.1. Glucometer Devices
- 6.2.1.2. Blood Glucose Test Strips
- 6.2.1.3. Lancets
- 6.2.2. Continuous Glucose Monitoring
- 6.2.2.1. Sensors
- 6.2.2.2. Durables (Receivers and Transmitters)
- 6.2.1. Self-monitoring Blood Glucose
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Hospital/Clinics
- 6.3.2. Home/Personal
- 6.1. Market Analysis, Insights and Forecast - by Management Devices
- 7. South America APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Management Devices
- 7.1.1. Insulin Pump
- 7.1.1.1. Technology
- 7.1.1.1.1. Tethered Insulin Pump
- 7.1.1.1.2. Tubeless Insulin Pump
- 7.1.1.2. Component
- 7.1.1.2.1. Insulin Pump Device
- 7.1.1.2.2. Insulin Pump Reservoir
- 7.1.1.2.3. Infusion Set
- 7.1.1.1. Technology
- 7.1.2. Insulin pens
- 7.1.2.1. Cartridges in Reusable Pens
- 7.1.2.2. Insulin Disposable Pens
- 7.1.3. Insulin Syringes
- 7.1.4. Jet Injectors
- 7.1.1. Insulin Pump
- 7.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.2.1. Self-monitoring Blood Glucose
- 7.2.1.1. Glucometer Devices
- 7.2.1.2. Blood Glucose Test Strips
- 7.2.1.3. Lancets
- 7.2.2. Continuous Glucose Monitoring
- 7.2.2.1. Sensors
- 7.2.2.2. Durables (Receivers and Transmitters)
- 7.2.1. Self-monitoring Blood Glucose
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Hospital/Clinics
- 7.3.2. Home/Personal
- 7.1. Market Analysis, Insights and Forecast - by Management Devices
- 8. Europe APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Management Devices
- 8.1.1. Insulin Pump
- 8.1.1.1. Technology
- 8.1.1.1.1. Tethered Insulin Pump
- 8.1.1.1.2. Tubeless Insulin Pump
- 8.1.1.2. Component
- 8.1.1.2.1. Insulin Pump Device
- 8.1.1.2.2. Insulin Pump Reservoir
- 8.1.1.2.3. Infusion Set
- 8.1.1.1. Technology
- 8.1.2. Insulin pens
- 8.1.2.1. Cartridges in Reusable Pens
- 8.1.2.2. Insulin Disposable Pens
- 8.1.3. Insulin Syringes
- 8.1.4. Jet Injectors
- 8.1.1. Insulin Pump
- 8.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.2.1. Self-monitoring Blood Glucose
- 8.2.1.1. Glucometer Devices
- 8.2.1.2. Blood Glucose Test Strips
- 8.2.1.3. Lancets
- 8.2.2. Continuous Glucose Monitoring
- 8.2.2.1. Sensors
- 8.2.2.2. Durables (Receivers and Transmitters)
- 8.2.1. Self-monitoring Blood Glucose
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Hospital/Clinics
- 8.3.2. Home/Personal
- 8.1. Market Analysis, Insights and Forecast - by Management Devices
- 9. Middle East & Africa APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Management Devices
- 9.1.1. Insulin Pump
- 9.1.1.1. Technology
- 9.1.1.1.1. Tethered Insulin Pump
- 9.1.1.1.2. Tubeless Insulin Pump
- 9.1.1.2. Component
- 9.1.1.2.1. Insulin Pump Device
- 9.1.1.2.2. Insulin Pump Reservoir
- 9.1.1.2.3. Infusion Set
- 9.1.1.1. Technology
- 9.1.2. Insulin pens
- 9.1.2.1. Cartridges in Reusable Pens
- 9.1.2.2. Insulin Disposable Pens
- 9.1.3. Insulin Syringes
- 9.1.4. Jet Injectors
- 9.1.1. Insulin Pump
- 9.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.2.1. Self-monitoring Blood Glucose
- 9.2.1.1. Glucometer Devices
- 9.2.1.2. Blood Glucose Test Strips
- 9.2.1.3. Lancets
- 9.2.2. Continuous Glucose Monitoring
- 9.2.2.1. Sensors
- 9.2.2.2. Durables (Receivers and Transmitters)
- 9.2.1. Self-monitoring Blood Glucose
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Hospital/Clinics
- 9.3.2. Home/Personal
- 9.1. Market Analysis, Insights and Forecast - by Management Devices
- 10. Asia Pacific APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Management Devices
- 10.1.1. Insulin Pump
- 10.1.1.1. Technology
- 10.1.1.1.1. Tethered Insulin Pump
- 10.1.1.1.2. Tubeless Insulin Pump
- 10.1.1.2. Component
- 10.1.1.2.1. Insulin Pump Device
- 10.1.1.2.2. Insulin Pump Reservoir
- 10.1.1.2.3. Infusion Set
- 10.1.1.1. Technology
- 10.1.2. Insulin pens
- 10.1.2.1. Cartridges in Reusable Pens
- 10.1.2.2. Insulin Disposable Pens
- 10.1.3. Insulin Syringes
- 10.1.4. Jet Injectors
- 10.1.1. Insulin Pump
- 10.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.2.1. Self-monitoring Blood Glucose
- 10.2.1.1. Glucometer Devices
- 10.2.1.2. Blood Glucose Test Strips
- 10.2.1.3. Lancets
- 10.2.2. Continuous Glucose Monitoring
- 10.2.2.1. Sensors
- 10.2.2.2. Durables (Receivers and Transmitters)
- 10.2.1. Self-monitoring Blood Glucose
- 10.3. Market Analysis, Insights and Forecast - by End User
- 10.3.1. Hospital/Clinics
- 10.3.2. Home/Personal
- 10.1. Market Analysis, Insights and Forecast - by Management Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Terumo
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Insulin Devices
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Roche Diabetes Care
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Abbott Diabetes Care
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Medtronic
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 LifeScan (Johnson & Johnson)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Becton Dickinson
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Novo Nordisk A/S
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Arkray
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Terumo
List of Figures
- Figure 1: Global APAC Diabetes Care Devices Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: Global APAC Diabetes Care Devices Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 4: North America APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 5: North America APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 6: North America APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 7: North America APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 8: North America APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 9: North America APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 10: North America APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 11: North America APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 12: North America APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 13: North America APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 14: North America APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 15: North America APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 16: North America APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 17: North America APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: North America APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 19: South America APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 20: South America APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 21: South America APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 22: South America APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 23: South America APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 24: South America APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 25: South America APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 26: South America APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 27: South America APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 28: South America APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 29: South America APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 30: South America APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 31: South America APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 32: South America APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 33: South America APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 35: Europe APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 36: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 37: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 38: Europe APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 39: Europe APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 40: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 41: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 42: Europe APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 43: Europe APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 44: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 45: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 46: Europe APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 47: Europe APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 48: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 49: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 50: Europe APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 51: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 52: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 53: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 54: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 55: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 56: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 57: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 58: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 59: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 60: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 61: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 62: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 63: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 64: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 65: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 66: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 67: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 68: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 69: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 70: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 71: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 72: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 73: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 74: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 75: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 76: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 77: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 78: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 79: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 80: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 81: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 82: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 2: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 3: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 4: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 5: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 6: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 8: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 10: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 11: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 12: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 13: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 14: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: United States APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: United States APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Canada APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Canada APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Mexico APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Mexico APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 24: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 25: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 26: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 27: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 28: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 29: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 31: Brazil APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Brazil APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: Argentina APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: Argentina APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: Rest of South America APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 36: Rest of South America APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 38: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 39: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 40: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 41: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 42: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 43: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 44: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 45: United Kingdom APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 46: United Kingdom APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 47: Germany APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 48: Germany APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 49: France APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 50: France APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 51: Italy APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 52: Italy APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Spain APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 54: Spain APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: Russia APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 56: Russia APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: Benelux APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 58: Benelux APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: Nordics APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 60: Nordics APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Europe APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Europe APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 64: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 65: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 66: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 67: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 68: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 69: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 70: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 71: Turkey APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 72: Turkey APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 73: Israel APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 74: Israel APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 75: GCC APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 76: GCC APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 77: North Africa APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 78: North Africa APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 79: South Africa APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 80: South Africa APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 81: Rest of Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 82: Rest of Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 83: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 84: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 85: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 86: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 87: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 88: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 89: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 90: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 91: China APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 92: China APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 93: India APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 94: India APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 95: Japan APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 96: Japan APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 97: South Korea APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 98: South Korea APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 99: ASEAN APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 100: ASEAN APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 101: Oceania APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 102: Oceania APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 103: Rest of Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 104: Rest of Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the APAC Diabetes Care Devices Industry?
The projected CAGR is approximately 3.50%.
2. Which companies are prominent players in the APAC Diabetes Care Devices Industry?
Key companies in the market include Terumo, Dexcom, Insulin Devices, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, Arkray.
3. What are the main segments of the APAC Diabetes Care Devices Industry?
The market segments include Management Devices, Monitoring Devices, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 22.77 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
November 2023: Sibionics, a Chinese company, has recently received a CE Mark for its GS1 continuous glucose monitoring system (CGM). This innovative wearable device utilizes an under-the-skin sensor to accurately measure glucose levels in real-time. The collected data is then seamlessly transmitted to a connected handset or mobile phone. The GS1 CGM provides users with a remarkable 14-day continuous glucose monitoring experience, eliminating the need for frequent calibration. Additionally, it empowers users to effortlessly transmit their glucose data to monitoring devices or mobile apps, enabling them to generate comprehensive and insightful professional reports.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "APAC Diabetes Care Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the APAC Diabetes Care Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the APAC Diabetes Care Devices Industry?
To stay informed about further developments, trends, and reports in the APAC Diabetes Care Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence